BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 11901921)

  • 1. Pathology of lung cancer.
    Travis WD
    Clin Chest Med; 2002 Mar; 23(1):65-81, viii. PubMed ID: 11901921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Classification of broncho-pulmonary cancers (WHO 1999)].
    Brambilla E
    Rev Mal Respir; 2002 Sep; 19(4):455-66. PubMed ID: 12417862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic type definition in clinical trials on advanced non-small cell lung cancer.
    Rossi G; Cavazza A
    J Thorac Oncol; 2011 Feb; 6(2):405. PubMed ID: 21252724
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantitative nuclear texture features analysis confirms WHO classification 2004 for lung carcinomas.
    Schmid K; Angerstein N; Geleff S; Gschwendtner A
    Mod Pathol; 2006 Mar; 19(3):453-9. PubMed ID: 16462732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Grading of lung cancer].
    Bohle RM; Schnabel PA
    Pathologe; 2016 Jul; 37(4):314-9. PubMed ID: 27356985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and biological relevance of recently defined categories of pulmonary neoplasia.
    Gabrielson E
    Methods Mol Med; 2003; 74():31-42. PubMed ID: 12415684
    [No Abstract]   [Full Text] [Related]  

  • 7. The significance of associated pre-invasive lesions in patients resected for primary lung neoplasms.
    Ruffini E; Bongiovanni M; Cavallo A; Filosso PL; Giobbe R; Mancuso M; Molinatti M; Oliaro A
    Eur J Cardiothorac Surg; 2004 Jul; 26(1):165-72. PubMed ID: 15200997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pulmonary neuroendocrine tumors and preneoplasic lesions].
    Rouquette Lassalle I
    Ann Pathol; 2016 Jan; 36(1):34-43. PubMed ID: 26776366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preneoplastic lesions of pulmonary carcinoma].
    Bubendorf L
    Pathologe; 2011 Nov; 32 Suppl 2():218-23. PubMed ID: 22033683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?].
    Schnabel PA; Junker K
    Pathologe; 2015 May; 36(3):283-92. PubMed ID: 25956813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of the Fourth Edition of the WHO Classification of Lung Tumours on Histological Classification of Resected Pulmonary NSCCs.
    Micke P; Mattsson JS; Djureinovic D; Nodin B; Jirström K; Tran L; Jönsson P; Planck M; Botling J; Brunnström H
    J Thorac Oncol; 2016 Jun; 11(6):862-72. PubMed ID: 26872818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Histological Classification of Lung Cancer (Japan Lung Cancer Society)].
    Ohawada H
    Nihon Rinsho; 2002 May; 60 Suppl 5():132-7. PubMed ID: 12101642
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognosis in lung carcinoid tumours. Is there a difference between atypical and typical carcinoids with and without metastasis?
    Sands TJ; Soomro IN; Chaudry ZR; Ronan J
    Histopathology; 2006 Dec; 49(6):653-4. PubMed ID: 17163851
    [No Abstract]   [Full Text] [Related]  

  • 14. [New data in the classification of pulmonary neuroendocrine proliferation].
    Lantuejoul S; Brambilla E
    Ann Pathol; 2000; 20 Suppl():S131-4. PubMed ID: 11261291
    [No Abstract]   [Full Text] [Related]  

  • 15. Next-Generation Sequencing of a Cohort of Pulmonary Large Cell Carcinomas Reclassified by World Health Organization 2015 Criteria.
    Driver BR; Portier BP; Mody DR; Deavers M; Bernicker EH; Kim MP; Teh BS; Santacruz JF; Kopas L; Munden RF; Cagle PT
    Arch Pathol Lab Med; 2016 Apr; 140(4):312-7. PubMed ID: 26430808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An assessment of the World Health Organization classification of the histologic typing of lung tumors applied to biopsy and resected material.
    Hinson KF; Miller AB; Tall R
    Cancer; 1975 Feb; 35(2):399-405. PubMed ID: 163133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The frequency of neuroendocrine cell hyperplasia in patients with pulmonary neuroendocrine tumours and non-neuroendocrine cell carcinomas.
    Rizvi SM; Goodwill J; Lim E; Yap YK; Wells AU; Hansell DM; Davis P; Selim AG; Goldstraw P; Nicholson AG
    Histopathology; 2009 Sep; 55(3):332-7. PubMed ID: 19723148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproducibility of neuroendocrine lung tumor classification.
    Travis WD; Gal AA; Colby TV; Klimstra DS; Falk R; Koss MN
    Hum Pathol; 1998 Mar; 29(3):272-9. PubMed ID: 9496831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the proposals of the international association for the study of lung cancer in the forthcoming edition of lung cancer staging system to predict long-term prognosis of operated patients.
    Rena O; Massera F; Robustellini M; Papalia E; Delfanti R; Lisi E; Pirondini E; Turello D; Casadio C
    Cancer J; 2010; 16(2):176-81. PubMed ID: 20404615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer preneoplasia.
    Wistuba II; Gazdar AF
    Annu Rev Pathol; 2006; 1():331-48. PubMed ID: 18039118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.